![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » RevMedx Receives CE Mark for Injectable Hemostatic Device
RevMedx Receives CE Mark for Injectable Hemostatic Device
April 6, 2018
RevMedx gained CE Mark certification for its XStat device, an injectable device that can achieve hemostasis in seconds.
The device is used to stop bleeding in patients, stabilizing injuries and giving them time to reach an emergency facility.
The XStat device uses a syringe-like applicator to inject a group of small, expanding sponges into a wound that swell and exert hemostatic pressure to stop bleeding.
Upcoming Events
-
21Oct